Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palifermin for Mucositis in Hematologic Malignancies
NCT00041665Phase 3Completed
- Sponsor
- Amgen
- Modality
- Cytokines & Interferons
01
Overview
A Phase 3 trial of palifermin in oral mucositis (OM), sponsored by Amgen. Status: completed.
02
Drugs
palifermin
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT00041665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00041665.